Morgan Stanley’s IQ US Large Cap R&D Leaders ETF LRND Stock Holding History

Morgan Stanley’s Portfolio LRND Stock Details LRND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$41	Buy	+1	New	+$40	﹤0.01%	8019
2025 Q3	–	Sell	-1	Closed	-$46	–	8279
2025 Q2	$46	Buy	+1	New	+$33	﹤0.01%	7810

Other funds holding LRND

NYLIM

New York Life Investment Management New York $14.3B AUM 34.42% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sankala Group Lyons, Colorado $122M AUM

Morgan Stanley's LRND Position: Q1 2026 in Review

Morgan Stanley opened a new position in IQ US Large Cap R&D Leaders ETF (LRND) in Q1 2026: 1 share worth $41. The stake represents ﹤0.01% of the portfolio and ranks #8019 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in LRND as recently as Q2 2025.

Morgan Stanley first reported a position in LRND in Q2 2025 and has held it in 2 quarters since. The position peaked at $46 in Q2 2025. 5 funds tracked by Wall St. Rank hold LRND as of Q1 2026.

Morgan Stanley held 1 share of IQ US Large Cap R&D Leaders ETF worth $41 as of Q1 2026.
IQ US Large Cap R&D Leaders ETF was a new Morgan Stanley position in Q1 2026.
IQ US Large Cap R&D Leaders ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #8019 holding.
Morgan Stanley first reported a position in IQ US Large Cap R&D Leaders ETF in Q2 2025 and has held it in 2 quarters since.
Morgan Stanley's IQ US Large Cap R&D Leaders ETF position peaked at $46 in Q2 2025.
5 funds tracked by Wall St. Rank held IQ US Large Cap R&D Leaders ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.